Sentence examples for complement capacity from inspiring English sources

To complement capacity building of individual health officials and organizations, a variety of other mechanisms are used by MOPH to get health concerns on the trade negotiation agenda: institutional mechanisms, interagency committees and working groups, the NHC and NHA and informal processes.

Social care of the future will be a professional vocation in which care workers have the freedom and responsibility to provide appropriate supports to strengthen and complement the capacity of the client and her networks – a rewarding career indeed.

Without long-term and large-scale energy storage systems to complement renewable capacity installations, which are not currently economically feasible [5], optimal generation management decisions are subject to disruption.

It was also aimed to show that the labeling did not modify the complement activation capacity of the nanoparticles which are designed as drug carriers for the in vivo delivery of siRNA.

And from the perspective of the World Bank is critical in leveraging private resources to complement public capacity in meeting the needs of the poor.

However, the documentary failed to recognize that the key question for understanding the difference between good and bad foreign assistance is the same one we must ask in the case of foreign direct investment: does this foreign intervention substitute (displace) or complement local capacity?

The alpha-chains contain the complement inhibitory capacity and present activated complement components C4b and C3b to factor I for degradation.

A functionally deficient (R53H FH mutant in heterozygous individuals would likely compete with wild-type FH for binding C3b and could thereby further diminish complement regulatory capacity [ 16].

Limitation to IgG3 in our three cases confirms the specific predilection for IgG3 to precipitate and self-aggregate in the glomeruli given its properties of high molecular weight, positive charge and complement activation capacity [ 7].

Even if this is the case, ASKP1240 is expected to be safe because prethrombotic anti-CD154 mAbs, such as hu5C8, IDEC-131 and ABI793, are comprised of recombinant IgG1, while ASKP1240 is IgG4, which has an extremely lower affinity for platelet FcγR and extremely lower complement activation capacity than IgG1 27.

The large continuing costs arising from invasive species demonstrate the limitations of government-centred (monocentric) approaches to governance in this domain, and indicate a need for polycentric alternatives which complement government capacities with those of landholders and their community organisations.